Table 1:
PAH Patient Population and Control Subjects
| N | |
|---|---|
| PHBI study | |
| Affected (associated PAH) | 20 |
| Affected (HPAH) | 6 |
| Affected (idiopathic PAH) | 38 |
| Affected (other) | 4 |
| Control subjects (failed donors) | 41 |
| Total | 109 |
| Vanderbilt study | |
| Affected (HPAH) | 40 |
| Unaffected carriers | 24 |
| Control subjects (noncarriers) | 16 |
| Control subjects (married-ins) | 44 |
| Total | 124 |
| Totals | |
| All PAH (affected) | 108 |
| Unaffected carriers | 24 |
| All control subjects | 101 |
| Total | 233 |
Definition of abbreviations: HPAH = hereditary pulmonary arterial hypertension; PAH = pulmonary arterial hypertension; PHBI = Pulmonary Hypertension Breakthrough Initiative.